✦ LIBER ✦

Cardiovascular Risk Factors in Renal Transplant Patients after Switch From Standard Tacrolimus to Prolonged-Release Tacrolimus

✍ Scribed by Sessa, A.; Esposito, A.; Iavicoli, G.; Lettieri, E.; Ragosta, G.; Rossano, R.; Capuano, M.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Conversion from cyclosporine to tacrolim

✍ Helge Hohage; U. Welling; M. Heck; M. Zeh; U. Gerhardt; B.M. Suwelack 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 199 KB

Clinical experience of conversion from t

✍ Wing Fai Pang; Kai Ming Chow; Bonnie Ching Ha Kwan; Vickie Wai Ki Kwong; Cheuk C 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 305 KB

Switch from Twice-Daily Tacrolimus (Prog

✍ G. Iaria; D. Sforza; R. Angelico; L. Toti; L. de Luca; M. Manuelli; I. Bellini; 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 155 KB

Switch From Twice-Daily Tacrolimus (Prog

✍ Jaksch, P.; Stromberger, R.; Murakoezy, G.; Lambers, C.; Klepetko, W. 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 157 KB

Renal function and safety in stable kidn

✍ Ricardo Lauzurica; José M. Morales; Johannes van Hooff; on behalf of the study i 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 276 KB

Is hepatitis C a risk factor to posttran

✍ P.E.S Finni; E.R.M Souza; S Rioja; S Ventura; P Starling; J.R Almeida; F Ruzany 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 53 KB